Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Danny S. C. Ng, Mary Ho, Lawrence P.L. Iu & Timothy Y.Y. Lai. (2022) Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization. Expert Opinion on Drug Safety 21:1, pages 43-54.
Read now
Read now
Anna Brinkmann, Katrin Winkelmann, Tom Käckenmeister, Johann Roider & Alexa Klettner. (2022) Effect of Long-term Anti-VEGF Treatment on Viability and Function of RPE Cells. Current Eye Research 47:1, pages 127-134.
Read now
Read now
Huan Liu, Yue Ma, Hong-Chang Xu, Li-Ying Huang, Li-Ying Zhai & Xiao-Rong Zhang. (2020) Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept. Current Eye Research 45:12, pages 1467-1476.
Read now
Read now
Xiaodan Jiang, Yuexin Wang, Huibin Lv, Yan Liu, Mingzhou Zhang & Xuemin Li. (2018) Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. Drug Design, Development and Therapy 12, pages 1269-1279.
Read now
Read now
Marion R. Munk, Rene Rückert, Martin Zinkernagel, Andreas Ebneter & Sebastian Wolf. (2016) The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook. Expert Opinion on Biological Therapy 16:4, pages 477-487.
Read now
Read now
Articles from other publishers (20)
Chuanzhen Xu, Xiaoming Xi, Lu Yang, Xiao Yang, Zuoyong Song, Xiushan Nie, Limei Zhang, Yanwei Zhang, Xinjian Chen & Yilong Yin. (2022) Feature enhancement network for CNV typing in optical coherence tomography images. Physics in Medicine & Biology 67:20, pages 205007.
Crossref
Crossref
Sara Aly Attia & J. Andrew MacKay. (2022) Protein and polypeptide mediated delivery to the eye. Advanced Drug Delivery Reviews 188, pages 114441.
Crossref
Crossref
Chuanzhen Xu, Xiaoming Xi, Xiao Yang, Liangyun Sun, Lingzhao Meng & Xiushan Nie. (2022) Local Detail Enhancement Network for CNV Typing in OCT Images. Local Detail Enhancement Network for CNV Typing in OCT Images.
Mukesh Jain, Raja Narayanan, Priya Jana, Ashik Mohamed, Rajiv Raman, Pavan Verkicharla, Srikanta Kumar Padhy, Anthony Vipin Das & Jay Chhablani. (2022) Incidence, predictors and re-treatment outcomes of recurrent myopic choroidal neo-vascularization. PLOS ONE 17:7, pages e0271342.
Crossref
Crossref
Shun-Fa Yang, Yu-Chen Su, Chen-Chee Lim, Jing-Yang Huang, Sheng-Min Hsu, Li-Wha Wu, Yi-Sheng Chang & Jia-Horung Hung. (2022) Risk of dialysis in patients receiving intravitreal anti–vascular endothelial growth factor treatment: a population-based cohort study. Aging 14:12, pages 5116-5130.
Crossref
Crossref
Lin Liu, Dan Zhu, Wenzhi Ding, Ting Zhang, Xiaoyun Ma & Jun Zou. (2022) MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs. Ophthalmic Research 65:5, pages 493-505.
Crossref
Crossref
Minjie Sheng, Haiying Cai, Ming Cheng, Jing Li, Jian Zhang & Lihua Liu. (2021) Identification of Novel Choroidal Neovascularization-Related Genes Using Laplacian Heat Diffusion Algorithm. BioMed Research International 2021, pages 1-10.
Crossref
Crossref
Shashikant Sharma, Tanishq Sharma, Somdutt Prasad, Mahesh Gopalakrishnan & Alok Chaturvedi. (2021) Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review. Ophthalmology and Therapy 10:3, pages 431-443.
Crossref
Crossref
Elena N. Shamitova, Konstantin G. Matkov, Darya D. Shikhranova & Ramis R. Abdullin. (2021) NEUTRALIZATION OF ANGIOPOIETIN-2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) FOR THERAPEUTIC PURPOSES. Acta medica Eurasica:2, pages 64-79.
Crossref
Crossref
Lele Li, Manhui Zhu, Wenli Wu, Bai Qin, Jiayi Gu, Yuanyuan Tu, Jianing Chen, Dong Liu, Yunwei Shi, Xiaojuan Liu, Aimin Sang & Dongmei Ding. (2019) Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD. Journal of Cellular Physiology 235:2, pages 1259-1273.
Crossref
Crossref
Chui Ming Gemmy Cheung, Jennifer J. Arnold, Frank G. Holz, Kyu Hyung Park, Timothy Y.Y. Lai, Michael Larsen, Paul Mitchell, Kyoko Ohno-Matsui, Shih-Jen Chen, Sebastian Wolf & Tien Yin Wong. (2017) Myopic Choroidal Neovascularization. Ophthalmology 124:11, pages 1690-1711.
Crossref
Crossref
Ya-Ning Shi, Neng Zhu, Chan Liu, Hong-Tao Wu, Yu Gui, Duan-Fang Liao & Li Qin. (2017) Wnt5a and its signaling pathway in angiogenesis. Clinica Chimica Acta 471, pages 263-269.
Crossref
Crossref
Ning Yang, Wenxi Zhang, Tao He & Yiqiao Xing. (2017) Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy. Experimental Eye Research 159, pages 1-15.
Crossref
Crossref
Daniel R. Moroz, Monique Munro & Michael P. Fielden. (2017) Intravitreal Anti-VEGF Treatment of Myopic Choroidal Neovascularization. Journal of VitreoRetinal Diseases 1:2, pages 109-115.
Crossref
Crossref
Lisa V. Stottlemyer. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
491
501
.
Wen-Chin Chiu, Tzeon-Jye Chiou, Meng-Ju Chung & An-Na Chiang. (2016) β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase. PLOS ONE 11:8, pages e0161950.
Crossref
Crossref
Beverly L. Falcon, Sudhakar Chintharlapalli, Mark T. Uhlik & Bronislaw Pytowski. (2016) Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents. Pharmacology & Therapeutics 164, pages 204-225.
Crossref
Crossref
Ruti Sella, Orly Gal-Or, Eitan Livny, Mor Dachbash, Yael Nisgav, Dov Weinberger, Tami Livnat & Irit Bahar. (2016) Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model. Experimental Eye Research 146, pages 224-232.
Crossref
Crossref
Bingwen Lu, Xingwei Wu & Lei Zhang. (2016) Clinical Study of “Lingqi Huangban Granule” in Treating Choroidal Neovascularisation in Pathologic Myopia. Chinese Medicine 07:04, pages 125-132.
Crossref
Crossref
Qin Long, Xiaoguang Cao, Ailing Bian & Ying Li. (2016) C3a Increases VEGF and Decreases PEDF mRNA Levels in Human Retinal Pigment Epithelial Cells. BioMed Research International 2016, pages 1-7.
Crossref
Crossref